2020
DOI: 10.21203/rs.3.rs-46074/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Significance of Coagulation and Fibrinolysis Markers for Benign and Malignant Soft Tissue Tumors

Abstract: Background: The intimate relationship between coagulation and fibrinolysis in malignant tumors is a well-known phenomena, with the malignant phenotype enhancing coagulation and fibrinolysis. We hypothesized that soft tissue sarcoma (STS) affects the expression of coagulation and fibrinolysis markers, which could be used to distinguish STS from benign soft tissue tumors. We analyzed the correlations between plasma levels of D-dimer (DD), plasmin-α2 plasmin inhibitor complex (PIC), soluble fibrin (SF), and throm… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Similarly, IPMN is usually non-malignant but was found to be more prone to progress into cancer in contrast to the other types of pancreatic cysts [4,9]. the disturbances in fibrinolysis [13,18]. Thromboembolic events are common in malignancy as cancer is linked to a 7-fold increase in the risk of venous thromboembolic events (VTE) [18].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, IPMN is usually non-malignant but was found to be more prone to progress into cancer in contrast to the other types of pancreatic cysts [4,9]. the disturbances in fibrinolysis [13,18]. Thromboembolic events are common in malignancy as cancer is linked to a 7-fold increase in the risk of venous thromboembolic events (VTE) [18].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, most recent guidelines recommend close monitoring with frequent imaging [4,[6][7][8][9]. Despite the fact that the risk of hypercoagulability is increased in cancer [10][11][12][13], it has not yet been established to be elevated in premalignant pancreatic tumors such as IPMN. Only a few articles reported the possible increased risk of hypercoagulability in patients with IPMN [14,15].…”
Section: Introductionmentioning
confidence: 99%